Thermo Fisher Scientific (TMO) Stock Rose While Jpmorgan Chase & Company Lifted Holding; Covey Capital Advisors Decreased Stake in Viad (VVI) as Valuation Declined

February 24, 2018 - By Winifred Garcia

Jpmorgan Chase & Company increased its stake in Thermo Fisher Scientific Inc (TMO) by 22.24% based on its latest 2017Q3 regulatory filing with the SEC. Jpmorgan Chase & Company bought 453,998 shares as the company’s stock rose 8.13% with the market. The institutional investor held 2.50 million shares of the industrial machinery and components company at the end of 2017Q3, valued at $465.33M, up from 2.04 million at the end of the previous reported quarter. Jpmorgan Chase & Company who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be bullish on the $84.90B market cap company. The stock increased 1.23% or $2.58 during the last trading session, reaching $211.71. About 827,286 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since February 24, 2017 and is uptrending. It has underperformed by 1.13% the S&P500.

Covey Capital Advisors Llc decreased its stake in Viad Corp (VVI) by 12.39% based on its latest 2017Q3 regulatory filing with the SEC. Covey Capital Advisors Llc sold 8,300 shares as the company’s stock declined 8.89% while stock markets rallied. The institutional investor held 58,679 shares of the business services company at the end of 2017Q3, valued at $3.57M, down from 66,979 at the end of the previous reported quarter. Covey Capital Advisors Llc who had been investing in Viad Corp for a number of months, seems to be less bullish one the $1.08B market cap company. The stock decreased 0.66% or $0.35 during the last trading session, reaching $53. About 44,970 shares traded. Viad Corp (NYSE:VVI) has risen 43.02% since February 24, 2017 and is uptrending. It has outperformed by 26.32% the S&P500.

Investors sentiment is 0.94 in Q3 2017. Its the same as in 2017Q2. It is the same, as 14 investors sold VVI shares while 51 reduced holdings. only 23 funds opened positions while 38 raised stakes. 17.49 million shares or 0.05% more from 17.48 million shares in 2017Q2 were reported. Kennedy Cap Management stated it has 182,668 shares. Hancock Hldg owns 19,000 shares. Los Angeles Mgmt And Equity has 4,865 shares for 0% of their portfolio. Royal Financial Bank Of Canada holds 20,039 shares. James Invest Research Inc has 0.1% invested in Viad Corp (NYSE:VVI) for 47,230 shares. Strs Ohio has 0% invested in Viad Corp (NYSE:VVI). Opus Cap Gru Limited Liability Company owns 63,243 shares or 0.88% of their US portfolio. Moreover, Sei Invests Communications has 0.01% invested in Viad Corp (NYSE:VVI). The New York-based Blackrock Incorporated has invested 0.01% in Viad Corp (NYSE:VVI). Us Savings Bank De holds 0% of its portfolio in Viad Corp (NYSE:VVI) for 380 shares. Piermont Management Incorporated reported 39,170 shares. Citigroup Incorporated accumulated 12,716 shares. Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 0% in Viad Corp (NYSE:VVI). Ubs Asset Americas holds 0% or 8,599 shares. The California-based Violich Mngmt has invested 0.06% in Viad Corp (NYSE:VVI).

Analysts await Viad Corp (NYSE:VVI) to report earnings on April, 26. They expect $-0.53 EPS, down 260.61% or $0.86 from last year’s $0.33 per share. After $-0.26 actual EPS reported by Viad Corp for the previous quarter, Wall Street now forecasts 103.85% negative EPS growth.

Since August 28, 2017, it had 0 insider buys, and 8 insider sales for $20.62 million activity. 360 shares were sold by HARRIS C MARTIN, worth $65,149 on Wednesday, August 30. Shares for $9.59M were sold by CASPER MARC N on Friday, December 15. Williamson Stephen also sold $1.05 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday, February 7. $721,091 worth of stock was sold by HORNSTRA PETER E on Tuesday, September 5. 33,327 shares valued at $7.32 million were sold by Herrema Gregory J. on Friday, February 2. 2,026 Thermo Fisher Scientific Inc. (NYSE:TMO) shares with value of $366,645 were sold by Shine Daniel P.

Jpmorgan Chase & Company, which manages about $453.26 billion US Long portfolio, decreased its stake in Gnc Hldgs Inc (Put) by 506,554 shares to 16,100 shares, valued at $139,000 in 2017Q3, according to the filing. It also reduced its holding in Sap Se (NYSE:SAP) by 24,169 shares in the quarter, leaving it with 97,344 shares, and cut its stake in Ishares Tr (SHV).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>